In this segment of The Motley Fool's everything-financials show,�Where the Money Is, banking analysts Matt Koppenheffer and David Hanson discuss the recent announcement of PacWest Bancorp's (NASDAQ: PACW ) intention to buy CapitalSource (NYSE: CSE ) .
David tells investors why this merger makes a lot of sense on paper but may not be a signal that the bank-M&A floodgates are set to open.
While opportunity may seem abundant with smaller bank stocks, many investors are still terrified about investing in big banking stocks after the crash, but the sector has one notable stand-out. In a sea of mismanaged and dangerous peers, it rises above as "The Only Big Bank Built to Last." You can uncover the top pick that Warren Buffett loves in The Motley Fool's�new report. It's free, so click here to access it now.
You can follow�David�and�Matt�on Twitter.
Top Chemical Stocks To Own Right Now: Hudbay Minerals Inc (HBM)
HudBay Minerals Inc., an integrated mining company, engages in the exploration and development of copper, zinc, and precious metals mines in North and South America. It primarily produces copper concentrates containing copper, gold, and silver; and zinc metal. The company principally owns underground 777 mine that covers an area of 4,400 hectares and is located in Flin Flon, Manitoba. It also owns ore concentrators and a zinc production facility in northern Manitoba and Saskatchewan. The company was founded in 1992 and is based in Toronto, Canada.
Advisors' Opinion:- [By Dan Caplinger]
Dan, however, does believe CEO Randy Smallwood has the experience necessary to deal with these challenges. Strategies may include obtaining better terms from existing partners such as Barrick Gold (NYSE: ABX ) , Goldcorp (NYSE: GG ) , and Hudbay Minerals (NYSE: HBM ) on future contracts.
Best Warren Buffett Companies To Invest In Right Now: Spdr Nuveen Barclays Capital Short Term Municipal Bond Etf (SHM)
SPDR Nuveen Barclays Short Term Municipal Bond ETF (the Fund), formerly SPDR Nuveen Barclays Capital Short Term Municipal Bond ETF, correspond generally to the price and yield performance of the Barclays Capital Managed Money Municipal Short Term Index (the Index). The Fund uses a passive management strategy designed to track the Index. The Index tracks publicly traded municipal bonds that cover the United States dollar-denominated, short-term tax exempt bond market, including state and local general obligation bonds, revenue bonds, insured bonds and pre-refunded bonds. The Fund�� investment manager is SSgA Funds Management, Inc. Advisors' Opinion:- [By Todd Rosenbluth]
Fortunately, there are some short-term muni ETFs to choose from. The largest is SPDR Nuveen Barclays Short-Term Muni Bond (SHM). About 65% of the bonds inside have a AA rating, with most of the remaining ones having a AAA rating.
Best Warren Buffett Companies To Invest In Right Now: PowerSecure International Inc (POWR)
PowerSecure International, Inc. provides energy and smart grid solutions to electric utilities and their commercial, institutional, and industrial customers. The company?s products and services include Interactive Distributed Generation power systems, smart grid monitoring for electric utilities, peak shaving and demand response, and standby power dispatch and control products; and switchgear products and systems under the NexGear brand name. It also offers utility infrastructure products and services, including transmission and distribution system construction and maintenance under the UtilityServices brand name; engineering, regulatory consulting, and electric grid system design services under the UtilityEngineering and PowerServices brand names; LED lighting for grocery, drug, and convenience stores under the EfficientLights brand name; other LED-based lighting, including street lights; lighting and efficiency products for commercial and industrial customers under the E nergyLite brand name; and LED lighting and lighting components for OEMs and electronics manufacturers, as well as for commercial, industrial, and consumer lighting applications under the IES brand name. PowerSecure serves electric utilities, as well as commercial, institutional, and industrial customers in the United States, the Mid-Atlantic, the Midwest, and the Gulf Coast regions. The company was formerly known as Metretek Technologies, Inc. and changed its name to PowerSecure International, Inc. in August 2007. PowerSecure International, Inc. was founded in 1991 and is headquartered in Wake Forest, North Carolina.
Advisors' Opinion:- [By MONEYMORNING]
A good choice here is Power Secure International Inc. (Nasdaq: POWR).
Power Secure International is a leader in combining electricity distribution with enhanced infrastructure protections. POWR is up 43% since being introduced to Energy Inner Circle readers a little over eight months ago.
- [By Monica Gerson]
PowerSecure International (NYSE: POWR) is estimated to post its Q4 earnings at $0.09 per share on revenue of $69.18 million.
CNinsure (NASDAQ: CISG) is projected to post its Q4 earnings at $0.10 per share.
Best Warren Buffett Companies To Invest In Right Now: Optimer Pharmaceuticals Inc.(OPTR)
Optimer Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing hospital specialty products worldwide. It develops products that treat gastrointestinal infections and related diseases. The company provides two late-stage anti-infective product candidates, including Fidaxomicin, a narrow spectrum antibiotic for the treatment of Clostridium difficile-infection, which completed two Phase 3 trials; and Pruvel, a prodrug in the fluoroquinolone class of antibiotics, has completed two Phase 3 trials for the treatment of infectious diarrhea, including traveler?s diarrhea. It also develops product candidates using its proprietary technology Optimer One-Pot Synthesis, a computer-aided technology that enables the rapid synthesis of various proprietary molecules. In addition, the company?s other pipeline product candidates consist of CEM-101 (OP-1068), a macrolide and ketolide antibiotic, which is in Phase 2 trials for the treatment of upper and lower respiratory tract infections; and OPT-822/821, a novel carbohydrate-based cancer immunotherapy, is in Phase 2/3 trials for the treatment of metastatic breast cancer. It has collaborative agreements with Astellas Pharma Europe Ltd.; Par Pharmaceuticals, Inc.; Nippon Shinyaku, Co., Ltd.; Cempra Pharmaceuticals, Inc.; Memorial Sloan-Kettering Cancer Center; and The Scripps Research Institute. Optimer Pharmaceuticals, Inc. was founded in 1998 and is based in San Diego, California.
Advisors' Opinion:- [By Keith Speights]
"Bidness" is good (part 2)
Obagi isn't the only company for which "bidness" is good. Antibiotic maker�Optimer Pharmaceuticals (NASDAQ: OPTR ) shares soared 22% this week on talk of interest by multiple potential buyers.
Best Warren Buffett Companies To Invest In Right Now: Sagent Pharmaceuticals Inc.(SGNT)
Sagent Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, sources, and markets pharmaceutical products, principally injectable-based generic equivalents to branded products in the United States. It offers a range of products across anti-infective, oncolytic, and critical care indications in various presentations, including single-and multi-dose vials, pre-filled ready-to-use syringes, and premix bags. The company?s anti-infective products include Levofloxacin, a fluoroquinolone antibacterial for the treatment of various infections caused by susceptible bacteria in adults of age 18 years or older; and Cefepime, an antibiotic used to treat infections of the urinary tract, and skin and skin structure, as well as moderate to severe pneumonia, intra-abdominal infections, and as empiric therapy for febrile neutropenic patients. Its oncology products comprise Gemcitabine, a nucleoside metabolic inhibitor used for the treatment of ovarian, breast, lung, and panc reatic cancers; and Topotecan, a topoisomerase inhibitor for small cell lung cancer sensitive disease. The company also offers critical care products consisting of Adenosine, an antiarrhythmic used for the treatment of cardiac rhythm disturbances; and Heparin, an anticoagulant used to prevent and treat blood clotting during and after surgery and dialysis. As of December 31, 2011, it marketed 33 generic injectable products; and had a new product pipeline that included 36 products represented by 63 Abbreviated New Drug Applications (ANDAs). The company sells its products to pharmaceutical wholesale companies, which then distribute the products to end-user hospitals, long-term care facilities, alternate care sites, and clinics. The company was formerly known as Sagent Holding Co. and changed its name to Sagent Pharmaceuticals, Inc. in April 2011. Sagent Pharmaceuticals, Inc. was founded in 2006 and is headquartered in Schaumburg, Illinois.
Advisors' Opinion:- [By CRWE]
Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, reported financial results for the quarter ended March 31, 2012.
- [By Roberto Pedone]
Sagent Pharmaceuticals (SGNT) is a pharmaceutical company engaged in developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectables. This stock closed up 1.1% at $23.58 in Thursday's trading session.
Thursday's Volume: 235,000
Three-Month Average Volume: 128,231
Volume % Change: 110%From a technical perspective, SGNT rose modestly higher here right above its 50-day moving average of $22.32 with above-average volume. This move pushed shares of SGNT into breakout territory, since the stock took out some near-term overhead resistance at $23.50. Shares of SGNT are now quickly moving within range of triggering another near-term breakout trade. That trade will hit if SGNT manages to clear its 52-week high at $24.27 with high volume.
Traders should now look for long-biased trades in SGNT as long as it's trending above its 50-day at $22.32 and then once it sustains a move or close above its 52-week high at $24.27 with volume that's near or above 128,231 shares. If that breakout hits soon, then SGNT will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are its next major overhead resistance levels at $26.74 to its all-time high at $29.23.
- [By Rich Smith]
Sagent Pharmaceuticals (NASDAQ: SGNT ) �is recalling three lots of Vecuronium Bromide for Injection, 10mg (NDC number 25021-657-10). Vecuronium Bromide for Injection is a neuromuscular blocking agent used in addition to general anesthesia to facilitate insertion of endotracheal tubes, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.�
Best Warren Buffett Companies To Invest In Right Now: Huntington Ingalls Industries Inc. (HII)
Huntington Ingalls Industries, Inc. designs, builds, overhauls, and repairs ships primarily for the U.S. Navy and Coast Guard. It offers nuclear-powered ships, such as aircraft carriers and submarines; and non-nuclear ships, including surface combatants, expeditionary warfare/amphibious assault, coastal defense surface ships, and national security cutters, as well as engages in the refueling and overhaul, and inactivation of nuclear-powered ships. The company also operates as a full-service systems provider for the design, engineering, construction, and life cycle support of major programs for surface ships; and a provider of fleet support and maintenance services for the U.S. Navy. In addition, it provides a range of support services, including fabrication, construction, equipment, and technical services, as well as product sales to commercial nuclear power plants, fossil power plants, and other industrial facilities, as well as government customers. The company is based in Newport News, Virginia.
Advisors' Opinion:- [By CRWE]
Huntington Ingalls Industries (NYSE:HII) reported that its Ingalls Shipbuilding division has been awarded an $83.3 million cost-plus-award-fee contract from the U.S. Navy for continued life-cycle engineering, modernization and support services on the U.S. Navy’s fleet of USS Ticonderoga-class (CG 47) Aegis guided missile cruisers.
- [By Monica Wolfe]
Huntington Ingalls Industries (HII)
Fournier�� fifth largest position is in Huntington Ingalls Industries. The guru holds on to 4,129,567 shares, representing 8.32% of the company�� shares outstanding and 4.3% of his total portfolio. The guru did not make any changes to his holdings in Huntington over the second quarter.
No comments:
Post a Comment